Unbound MEDLINE

[Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers] Cardiologia (Rome, Italy) [Cardiologia] Journal article

 
Title[Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers]
Author(s)Sau F, Seguro C, Pargentino E 
InstitutionIstituto di Cardiologia, Università degli Studi, Cagliari.
SourceCardiologia 1994 Jul; 39(7):473-9.
MeSHAcebutolol
Adolescent
Adrenergic beta-Antagonists
Adult
Aged
Antihypertensive Agents
Comparative Study
Echocardiography
English Abstract
Female
Hemodynamic Processes
Humans
Hypertension
Hypertrophy, Left Ventricular
Indenes
Male
Middle Aged
Oxprenolol
Pindolol
Propanolamines
Time Factors
AbstractTo define the time course of regression of left ventricular hypertrophy (LVH) during antihypertensive therapy with beta-blocking agents, 73 hypertensive patients were serially studied by echocardiography during 12-months therapy with beta-blockers. Blood pressure decreased significantly after 1 month and further on after 12 months (from 164 +/- 18/110 +/- 9 to 139 +/- 14/94 +/- 7 mmHg, p < 0.001). Left ventricular (LV) end-diastolic dimension increased significantly after 1 month (from 51.2 +/- 3.9 to 52.2 +/- 4.7 mm, p < 0.01) and decreased after 12 months (50.4 +/- 4.0 mm, p < 0.05). Septal and posterior wall thickness decreased progressively after 1 month and 3 months, respectively. LV mass index decreased significantly after 3 months, and further on after 12 months (from 164 +/- 42 to 145 +/- 33 g/m2, p < 0.001). LV fractional shortening did not significantly change throughout the study. Thus, a reduction of hypertensive LVH occurred after 3 months of therapy with beta-blocking agents and went on during the subsequent months without impairment of LV systolic function.
Languageita
Pub Type(s)Journal Article
PubMed ID7982244
  
Advertise on this site.